Schmid, P., Abraham, J., Chan, S., Wheatley, D., Brunt, M., Nemsadze, G., Baird, R., Hee Park, Y., Hall, P., Perren, T., Stein, R. C., László, M., Ferrero, J.-M., Phillips, M., Conibear, J., Sarker, S.-J., Prendergast, A., Cartwright, H., Mousa, K., & Turner, N. C. (2018, June). AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial. Presented at 2018 ASCO Annual Meeting I, Chicago, IL, USA